Essential antibiotics are losing their effectiveness against the typhoid germs.

 The bacteria that cause typhoid fever are growing more and more resistant to some of the most crucial medications for human health, according to a research reported in the Lancet Microbe journal. Almost all of the resistant strains of Salmonella enterica serovar Typhi (S. Typhi), which originated in South Asia, have spread to other nations nearly 200 times since 1990, according to the largest genome analysis of S. Typhi.

Since typhoid fever results in more than 100,000 fatalities annually and 11 million illnesses, it is a major public health concern worldwide. Even though South Asia, which makes up 70% of the world's disease burden, has the highest prevalence, it also has a substantial impact on sub-Saharan Africa, Southeast Asia, and Oceania, underscoring the need for a worldwide response. Typhoid fever infections can be successfully treated with antibiotics, but the rise of resistant S. Typhi strains poses a threat to their efficacy.

3,489 S were subjected to whole-genome sequencing by US researchers from Stanford University. Typhi isolates derived from blood samples taken in Bangladesh, India, Nepal, and Pakistan between 2014 and 2019 from individuals with confirmed cases of typhoid fever. a grouping of 4,169 S. Typhi samples that were collected from more than 70 different nations between 1905 and 2018 were also sequenced and analysed.

Genetic databases were used to find genes in the 7,658 sequenced genomes that confer resistance. If a strain had genes that made it resistant to the traditional first-line medicines ampicillin, chloramphenicol, and trimethoprim/sulfamethoxazole, it was categorised as multidrug-resistant (MDR). In addition, the scientists looked for genes that conferred resistance to macrolides and quinolones, two of the most vitally necessary antibiotics for human health.

MDR S. Typhi has steadily decreased since 2000 in Bangladesh, India, and Nepal, where it has stayed low (less than 5% of Typhoid strains), however it has significantly grown in Pakistan. However, bacteria that are resistant to other medicines are replacing them. For instance, quinolone resistance-causing gene changes have appeared and spread at least 94 times since 1990, with almost all of them (97%) coming from South Asia.

By the early 2000s, quinolone-resistant strains made up more than 85% of S. Typhi in Bangladesh; by 2010, this proportion had risen to more than 95% in India, Pakistan, and Nepal. At least seven times in the previous 20 years, mutations producing resistance to azithromycin, a popular macrolide antibiotic, have been discovered. Around 2013, strains with these mutations first appeared in Bangladesh, and since then, their number has grown gradually. The findings support recent data showing the rapid emergence and dissemination of S. Typhi strains resistant to third-generation cephalosporins, a class of antibiotics vital to human health.

"The speed at which highly-resistant strains of S. Typhi have emerged and spread in recent years is a real cause for concern, and highlights the need to urgently expand prevention measures, particularly in countries at greatest risk. At the same time, the fact resistant strains of S. Typhi has spread internationally so many times also underscores the need to view typhoid control, and antibiotic resistance more generally, as a global rather than local problem," said lead author Dr Jason Andrews at Stanford.